The long term risk of lead failure in patients with cardiovascular implantable electronic devices undergoing catheter ablation.
Michal Miroslaw FarkowskiAleksander MaciagJan CiszewskiIlona KowalikPawel SyskaMaciej SterlinskiHanna SzwedMariusz PytkowskiPublished in: Scandinavian cardiovascular journal : SCJ (2019)
Objectives. The aim of the study was to assess the long-term influence of catheter ablation (CA) of different arrhythmias on cardiovascular implantable electronic devices (CIED) endocardial leads durability. Design. This was a retrospective case-control study. Ablation protocols and in- or outpatient medical records were reviewed to identify and extract data on adult patients with CIED undergoing a CA. A cohort of patients with hypertrophic cardiomyopathy and implantable cardioverter-defibrillators (ICD) served as a historical control group. The primary endpoint was the diagnosis of lead damage defined as permanent loss of proper function demanding replacement or removal. Results. Among 145 patients n = 177 catheter ablations were performed. Patients' mean age was 66.4 ± 10.5, 66.1% had an ICD or ICD with cardiac resynchronization function (CRT-D), 18.1% had >1 CA. During median 812 days [IQR 381-1588] of follow-up, there were 11 (6.2%) cases of lead damage in the examined and 13 cases (13%) in the control group, p = 0.054. None of the technical aspects of the CA (indication, type of catheter, transseptal sheath) influenced the primary outcome. Both the number of leads and observation time after CA were significantly related to the risk of endocardial lead damage. Conclusion. This study did not find any significant influence of CA on the long-term durability of CIED endocardial leads. Reported risk factors were consistent with general population of CIED patients.
Keyphrases
- catheter ablation
- end stage renal disease
- atrial fibrillation
- oxidative stress
- risk factors
- hypertrophic cardiomyopathy
- left ventricular
- ejection fraction
- newly diagnosed
- chronic kidney disease
- cardiac resynchronization therapy
- left atrial
- protein kinase
- prognostic factors
- healthcare
- heart failure
- left atrial appendage
- patient reported outcomes
- electronic health record
- data analysis
- anti inflammatory
- big data